OXYN-AVENIR 3015mg

Pays: Israël

Langue: anglais

Source: Ministry of Health

Achète-le

Notice patient Notice patient (PIL)
11-04-2021

Ingrédients actifs:

NALOXONE HYDROCHLORIDE (AS DIHYDRATE); OXYCODONE HYDROCHLORIDE

Disponible depuis:

BIOAVENIR LTD, ISRAEL

Code ATC:

N02AA55

forme pharmaceutique:

TABLETS PROLONGED RELEASE

Composition:

OXYCODONE HYDROCHLORIDE 30 MG; NALOXONE HYDROCHLORIDE (AS DIHYDRATE) 15 MG

Mode d'administration:

PER OS

Type d'ordonnance:

Required

Fabriqué par:

DEVELCO PHARMA GMBH, GERMANY

Domaine thérapeutique:

OXYCODONE AND NALOXONE

indications thérapeutiques:

Indicated for the relief of moderate to severe pain. The oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. The opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

Date de l'autorisation:

2020-10-28

Notice patient

                                PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) - 1986
This medicine is dispensed with a doctor’s prescription only
OXYN-AVENIR 5/2.5 MG, OXYN-AVENIR 10/5 MG, OXYN-AVENIR
20/10 MG, OXYN-AVENIR 30/15 MG, OXYN-AVENIR 40/20 MG
PROLONGED RELEASE TABLETS
ACTIVE INGREDIENTS:
PRODUCT
oxycodone hydrochloride
naloxone hydrochloride
OXYN-AVENIR 5/2.5 MG
5 mg
2.5 mg
OXYN-AVENIR 10/5 MG
10 mg
5 mg
OXYN-AVENIR 20/10 MG
20 mg
10 mg
OXYN-AVENIR 30/15 MG
30 mg
15 mg
OXYN-AVENIR 40/20 MG
40 mg
20 mg
For a list of the other ingredients see section 6.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE. This
leaflet contains concise information about this medicine. If you have
any further
questions, consult your doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others. It may
harm them, even if it seems to you that their medical condition is
similar to yours.
Medicines of the opioid group can cause addiction, especially with
prolonged
use, and have potential for abuse and overdose. The reaction to
overdose can
be slow breathing and even death.
Make sure you know the name of your medicine, the dosage you are
taking,
how often you take it, the duration of your treatment, its side
effects and
potential
risks.
Additional information about the risk of dependence and addiction can
be found at:
https://www.health.gov.il/UnitsOffice/HD/MTI/Drugs/risk/DocLib/opioids_en.pdf
Taking this medicine with medicines in the benzodiazepine group, other
medicines that depress the central nervous system (including
psychoactive
drugs)
or
alcohol
may
cause
profound
drowsiness,
breathing
difficulties
(respiratory depression), coma and death.
1. WHAT IS THIS MEDICINE INTENDED FOR?
This medicine is intended for relieving moderate to severe pain.
THERAPEUTIC GROUP: oxycodone - opioid analgesic, naloxone - opioid
antagonist.
There are two active ingredients in Oxin-Avenir. The opioid ingredient
of Oxyn-
Avenir (oxycodone) is intended to relieve moderate or severe pain in
                                
                                Lire le document complet
                                
                            

Documents dans d'autres langues

Notice patient Notice patient arabe 11-04-2021
Notice patient Notice patient hébreu 11-04-2021

Rechercher des alertes liées à ce produit

Afficher l'historique des documents